Above 'optimal PEEP' levels, the PVR increased, presumably due to compression of intra-alveolar capillaries by the increased airway pressure resulting in an increase in zone 1 and 2 characteristics [23],[23].
The increase in zone of inhibition of silver nanoparticles at different concentrations (10, 25, 50 mg/L) compared with antibiotic for both bacterial cultures (Fig. 13a, b) demonstrated the lesser antibacterial potential of silver nanoparticles with that of antibiotics.
A ≥5-mm increase in zone diameter for i) cefoxitin (FOX) and/or cefotetan (CTT) containing BA versus FOX and/or CTT alone was considered positive for AmpC; ii) ceftazidime (CAZ -clavulanate (CAZ -clavulanateaxime (CAX)–Cand/ored in cefotaximen with BA versus CTX CA/or Ctestedtaining BA was combinationpositive for ESBL.
An increase in zone diameter of 5 mm in the presence of clavulanic acid indicated the presence of ESBL in the test organisms.
For these isolates, the ESBL phenotypic confirmation was performed with ceftazidime-clavulanate for an increase in zone diameter by 5 mm (disk potentiation).
The zone of inhibition ranged between 17 29 mm at 32 mg mL−1 of chlorogenic acid and a consistent increase in zone sizes were observed at increasing concentrations of the chlorogenic acid.
Above 'optimal PEEP' levels, the PVR increased, presumably due to compression of intra-alveolar capillaries by the increased airway pressure resulting in an increase in zone 1 and 2 characteristics [ 23],[ 59].
An increase in zone size of more than or equal to 7 mm for imipenem-EDTA disk compared to imipenem disk alone indicated MBL producer strain as described by Yong et al. [ 27].
An increase in zone size of more than or equal to 5 mm for cefotaxime and ceftazidime with and without clavulanic acid indicated ESBL production as described by Carter et al. [ 26].
We also noted NECs in the earliest ICE injuries at 4 days, but their density in our human tissue samples peaked in lesions of 30 50 days old, with a marginally earlier increase in zone 2 than in zone 1. NECs were more often MCM2- or PAX6-positive than GFAP-positive glia studied but with a significant regression of their regenerative activity over time, particularly after 28 weeks.
